Eliza F Chakravarty

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. doi Obstetric outcomes in women with multiple sclerosis and epilepsy
    Victoria M Kelly
    Department of Medicine, Stanford University School of Medicine, Stanford, CA 94304, USA
    Neurology 73:1831-6. 2009
  2. ncbi Risk of skin cancer in the drug treatment of rheumatoid arthritis
    Eliza F Chakravarty
    Stanford University School of Medicine, Division of Immunology and Rheumatology, 1000 Welch Road, Suite 203, Palo Alto, Stanford, CA 94304, USA
    Expert Opin Drug Saf 7:539-46. 2008
  3. ncbi Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus
    Eliza F Chakravarty
    Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, CA 94304, USA
    Am J Obstet Gynecol 192:1897-904. 2005
  4. pmc Reduced disability and mortality among aging runners: a 21-year longitudinal study
    Eliza F Chakravarty
    Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, California, USA
    Arch Intern Med 168:1638-46. 2008
  5. pmc Long distance running and knee osteoarthritis. A prospective study
    Eliza F Chakravarty
    Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California 94304, USA
    Am J Prev Med 35:133-8. 2008
  6. ncbi Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis
    Eliza F Chakravarty
    Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, California, USA
    Arthritis Rheum 54:899-907. 2006
  7. pmc Pregnancy outcomes in systemic sclerosis, primary pulmonary hypertension, and sickle cell disease
    Eliza F Chakravarty
    Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California, USA
    Obstet Gynecol 111:927-34. 2008
  8. doi Pregnancy outcomes after maternal exposure to rituximab
    Eliza F Chakravarty
    Division of Immunology and Rheumatology, Stanford University School of Medicine, 1000 Welch Road, Palo Alto, CA 94304, USA
    Blood 117:1499-506. 2011
  9. ncbi A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoarthritis of the hands
    Molly D Magnano
    Division of Immunology and Rheumatology, Stanford University, Palo Alto, California 94304, USA
    J Rheumatol 34:1323-7. 2007
  10. doi Immunosuppressive medications during pregnancy and lactation in women with autoimmune diseases
    Amy B Elliott
    Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, CA 94304, USA
    Womens Health (Lond Engl) 6:431-40; quiz 441-2. 2010

Detail Information

Publications25

  1. doi Obstetric outcomes in women with multiple sclerosis and epilepsy
    Victoria M Kelly
    Department of Medicine, Stanford University School of Medicine, Stanford, CA 94304, USA
    Neurology 73:1831-6. 2009
    ....
  2. ncbi Risk of skin cancer in the drug treatment of rheumatoid arthritis
    Eliza F Chakravarty
    Stanford University School of Medicine, Division of Immunology and Rheumatology, 1000 Welch Road, Suite 203, Palo Alto, Stanford, CA 94304, USA
    Expert Opin Drug Saf 7:539-46. 2008
    ..With increasing use of targeted biologic therapies, including those that may theoretically interfere with innate tumor surveillance, there is increasing concern about the development of other malignancies...
  3. ncbi Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus
    Eliza F Chakravarty
    Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, CA 94304, USA
    Am J Obstet Gynecol 192:1897-904. 2005
    ..The purpose of this study was to describe the outcomes of a 10-year cohort of pregnancies in patients with systemic lupus erythematosus and to evaluate clinical and laboratory markers for adverse outcomes...
  4. pmc Reduced disability and mortality among aging runners: a 21-year longitudinal study
    Eliza F Chakravarty
    Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, California, USA
    Arch Intern Med 168:1638-46. 2008
    ..Exercise has been shown to improve many health outcomes and well-being of people of all ages. Long-term studies in older adults are needed to confirm disability and survival benefits of exercise...
  5. pmc Long distance running and knee osteoarthritis. A prospective study
    Eliza F Chakravarty
    Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California 94304, USA
    Am J Prev Med 35:133-8. 2008
    ..The objective of this study was to determine if differences in the progression of knee OA in middle- to older-aged runners exist when compared with healthy nonrunners over nearly 2 decades of serial radiographic observation...
  6. ncbi Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis
    Eliza F Chakravarty
    Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, California, USA
    Arthritis Rheum 54:899-907. 2006
    ....
  7. pmc Pregnancy outcomes in systemic sclerosis, primary pulmonary hypertension, and sickle cell disease
    Eliza F Chakravarty
    Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California, USA
    Obstet Gynecol 111:927-34. 2008
    ..We estimated the nationwide occurrence of pregnancies in women with these conditions and compared pregnancy outcomes to the general obstetric population...
  8. doi Pregnancy outcomes after maternal exposure to rituximab
    Eliza F Chakravarty
    Division of Immunology and Rheumatology, Stanford University School of Medicine, 1000 Welch Road, Palo Alto, CA 94304, USA
    Blood 117:1499-506. 2011
    ..Practitioners are encouraged to report complete information to regulatory authorities for all pregnancies with suspected or known exposure to rituximab...
  9. ncbi A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoarthritis of the hands
    Molly D Magnano
    Division of Immunology and Rheumatology, Stanford University, Palo Alto, California 94304, USA
    J Rheumatol 34:1323-7. 2007
    ..To determine if anti-tumor necrosis factor (TNF) therapy (adalimumab) can safely improve symptoms of erosive/inflammatory osteoarthritis (EOA)...
  10. doi Immunosuppressive medications during pregnancy and lactation in women with autoimmune diseases
    Amy B Elliott
    Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, CA 94304, USA
    Womens Health (Lond Engl) 6:431-40; quiz 441-2. 2010
    ....
  11. ncbi Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors
    Eliza F Chakravarty
    Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA
    J Rheumatol 32:2130-5. 2005
    ....
  12. doi Management of rheumatic diseases during pregnancy
    Amy B Elliott
    Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, CA 94304, USA
    Postgrad Med 122:213-21. 2010
    ..Data are mixed regarding the impact of breastfeeding on underlying autoimmune diseases; the choice to continue breastfeeding is a personal decision...
  13. ncbi Associations between rheumatoid arthritis and malignancy
    Eliza F Chakravarty
    Division of Immunology and Rheumatology, Stanford University School of Medicine, 1000 Welch Road, 203, Palo Alto, CA 94303, USA
    Rheum Dis Clin North Am 30:271-84, vi. 2004
    ....
  14. ncbi Successful use of rituximab for cutaneous vasculitis
    Lorinda Chung
    Stanford University School of Medicine, Stanford, CA 94305, USA
    Arch Dermatol 142:1407-10. 2006
  15. pmc Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data
    Eliza F Chakravarty
    Stanford University School of Medicine, Stanford, California, USA
    Arthritis Rheum 56:2092-4. 2007
  16. doi High rate of preterm birth in pregnancies complicated by rheumatoid arthritis
    Elizabeth S Langen
    Department of Obstetrics and Gynecology, Stanford University, Stanford, California
    Am J Perinatol 31:9-14. 2014
    ..To describe the outcomes of pregnancies complicated by rheumatoid arthritis (RA) and to estimate potential associations between disease characteristics and pregnancy outcomes...
  17. ncbi Science as experiment; science as observation
    Eliza F Chakravarty
    Division of Immunology and Rheumatology, Stanford University School of Medicine, CA 94304, USA
    Nat Clin Pract Rheumatol 2:286-7. 2006
  18. pmc Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in Medicare managed care plans
    Gabriela Schmajuk
    Stanford University, Department of Medicine, Division of Rheumatology, 1000 Welch Rd, Ste 203, Stanford, CA 94304, USA
    JAMA 305:480-6. 2011
    ..In 2005, the Healthcare Effectiveness Data and Information Set (HEDIS) introduced a quality measure to assess the receipt of disease-modifying antirheumatic drugs (DMARDs) among patients with rheumatoid arthritis (RA)...
  19. ncbi The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes
    Eliza F Chakravarty
    Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA
    J Rheumatol 30:241-6. 2003
    ....
  20. ncbi Improving patient reported outcomes using item response theory and computerized adaptive testing
    Eliza F Chakravarty
    Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California, USA
    J Rheumatol 34:1426-31. 2007
    ....
  21. ncbi Thrombotic microangiopathic hemolytic anemia in a patient with SLE: diagnostic difficulties
    Ami A Shah
    Division of Rheumatology, Department of Medicine, at The Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Nat Clin Pract Rheumatol 3:357-62. 2007
    ..A 19-year-old woman with newly diagnosed systemic lupus erythematosus (SLE) presented with hemolytic anemia, thrombocytopenia, hypertension, tonic-clonic seizures, blurry vision, nephrotic syndrome and renal insufficiency...
  22. ncbi A randomized, blinded, parallel group, placebo controlled pilot study evaluating the effect of PVAC treatment in patients with diffuse systemic sclerosis
    Mark C Genovese
    Division of Immunology and Rheumatology, Stanford University, Palo Alto, California, USA
    J Rheumatol 32:2345-50. 2005
    ..We evaluated the safety and possible biologic effect of intradermal injections of PVAC in patients with diffuse SSc...
  23. pmc Excess female siblings and male fetal loss in families with systemic lupus erythematosus
    Rachna Aggarwal
    Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA
    J Rheumatol 40:430-4. 2013
    ..We aimed to determine whether the male-female ratio in SLE families is different from what would be expected by chance, and whether excess male fetal loss is found...
  24. doi What we talk about when we talk about contraception
    Eliza F Chakravarty
    Arthritis Rheum 59:760-1. 2008
  25. ncbi Coronary artery disease in patients with systemic lupus erythematosus
    Michael Galindo
    David Geffen School of Medicine at University California, Los Angeles, USA
    Nat Clin Pract Rheumatol 1:55-9; quiz 60. 2005
    ..Long-term medications included prednisolone, hydroxychloroquine, aspirin, and mycophenolate mofetil...